Studies - MUJHU Research Collaboration - Page 11

2022 Birth Defects Surveillance Studies

Mobile tablets for real-time data collection for hospital-based birth defects surveillance in Kampala, Uganda: Lessons learned

2022 PROMOTE Studies

Effects of long-term antiretroviral therapy in reproductive-age women in sub-Saharan Africa (the PEPFAR PROMOTE study): a multi-country observational cohort study.

2022 Mirasol Studies

The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial.

2022 HPTN-084 Studies

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

2022 Studies Tuberculosis

Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.

2022 COVID-19 Studies

Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries

2022 Birth Defects Surveillance Studies

Prevalence of neural tube defects, maternal HIV status, and antiretroviral therapy from a hospital-based birth defect surveillance in Kampala, Uganda

Epidemiology of tuberculosis in children in Kampala district, Uganda, 2009-2010; a retrospective cross-sectional study

Cardiac Dysfunction Among Ugandan HIV-Infected Children on Antiretroviral Therapy

2015 Studies The Nevirapine Repeat Pregnancy study

A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study”